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Siderophores are iron-chelating compounds that aid iron uptake, one of the key strategies for
microorganisms to carve out ecological niches in microbially diverse environments. Desferrioxamines
are the principal siderophores produced by Streptomyces spp. Their biosynthesis has been well studied
and as a consequence, the chemical potential of the pathway continues to expand. With all of this in
mind, our study aimed to explore extremotolerant and lupine rhizosphere-derived Streptomyces sp. S29
for its potential antifungal capabilities. Cocultivation of isolate S29 was carried out with Aspergillus niger
and Botrytis cinerea, both costly fungal phytopathogens in the wine industry, to simulate their
interaction within the rhizosphere. The results indicate that not only is Streptomyces sp. S29
extraordinary at producing hydroxamate siderophores but uses siderophore production as a means to
‘starve’ the fungi of iron. High resolution LC-MS/MS followed by GNPS molecular networking was used
to observe the datasets for desferrioxamines and guided structure elucidation of new desferrioxamine
analogues. Comparing the new chemistry, using tools like molecular networking and MS2LDA, with the
known biosynthesis, we show that the chemical potential of the desferrioxamine pathway has further
room for exploration.
Introduction
The application of Streptomyces secondary metabolites goes
beyond drug discovery, as they are one of the most important
bacteria for crop protection. Their biotechnological application
as rhizosphere or endophytic bacteria is proven to confer
protection against soilborne pathogens like fungi, nematodes,
and other bacteria.1,2 They serve as an important factor in
‘disease suppressive soils’, with several mechanisms of action
including synthesis of plant growth regulators,3 antibiotic
production,2 secretion of volatile compounds,4 and siderophore
production.5 The last of these is not only a way for bacteria
to uptake vital metals from the surrounding soil but also to
sequester metals in order to gain a competitive edge against other
soilborne organisms.
Rhizosphere-associated microbes are one of the many strate-
gies currently being explored as biocontrol agents. Bacterial
communities in the rhizosphere contribute to the extremely
complex flow of nutrients as well as the export of antibiotics
and other secondary metabolites into the soil.6,7 Model organisms
from genera like Bacillus and Pseudomonas have traditionally been
promising sources due to their association to the soil and their
production of secondary metabolites like lipopeptides but also
plant growth promotors.8,9 Actinobactera, which are also pre-
dominantly soil-associated microbes, have also been explored as
biocontrol agents due to their prolific antimicrobial potential.10
This combined with the fact that extremotolerant microbes have
adapted to the harsh conditions and the potential of these
adaptations to be translatable to biotechnologies, extremotolerant
microbes look to be promising sources as biocontrol agents.11
In Chile, the wine industry is the main agricultural export,
estimated at B$2 billion USD in 2017,12 thus driving a large
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research interest around protection of wine-producing grapes
against various phytopathogens.
Siderophores are iron-chelating compounds that aid metal
uptake in iron deficient environments.13 These secondary
metabolites are produced by all microbes and four types of
siderophore-mediated social interactions have been observed:
uptake among clonal cells (sharing), cheating or piracy (which
can only happen amongst microbes with the same uptake
receptor), competition via locking away and metabolite compe-
tition (whichever microbe makes the most cost efficient and
effective chelator).14 Desferrioxamines (DFO) are the most
widely observed group of siderophores in Streptomyces spp.,
used principally for Fe(III) scavenging,13,15 as well as some other
heavy metals.16–18 Since the vast majority of organisms require
Fe(III) in order to maintain proper cell wall function,13 as one
scavenges for itself, it simultaneously starves other competing
organisms, rendering them potentially unviable.
The biosynthetic machinery of desferrioxamines has been
well studied19–21 and as a consequence, the chemical potential
continues to expand. The substrate specificity of DesC-like
proteins, similar to acyl CoA-dependent transferases, seems
to be the key factor in producing diverse desferrioxamine
scaffolds.19,21 It has been shown that DesC can accommodate
for acetyl, succinyl, and myristol-CoA, with the latter providing
insight into the production of acyl desferrioxamines.19 Addi-
tionally, aryl desferrioxamines, first isolated from Micrococcus
luteus KLE101122 and later from Streptomyces sp. MA37,23
showed further substrate flexibility, where the latter commu-
nication described a new biosynthetic gene cluster (BGC) which
contained a DesC homolog (LgoC). This enzyme promiscuity
fits ideally with the Screening Hypothesis first proposed by
Firn and Jones; secondary metabolism stems from metabolic
pathways that ‘maximize diversity and minimize cost’.24
Due to the modular nature of desferrioxamines and the
presence of peptide bonds throughout their structure, mass
spectrometry-based studies have been utilized extensively to
not only study their biological impact but also for elucidation of
new structures. Previous studies have established standard
fragmentation patterns of these siderophores, even as far as
elucidating new structures solely based on mass spectrometry.25–31
This standardized fragmentation makes the discovery of sidero-
phores much easier thanks to metabolomics-based tools like
Global Natural Products Social Molecular Networking (GNPS). It
allows for correlations to be drawn within your dataset and against
the GNPS library that relates similar MS/MS spectra to one another,
forming clusters or families of similar features.32
With all of this in mind, our study originally aimed to
explore extremotolerant, rhizosphere-derived Streptomyces
sp. S29, a novel strain, for antifungal secondary metabolites.
Cocultivation of S29 with Aspergillus niger and Botrytis cinerea,
both costly fungal phytopathogens in the wine industry, were
carried out in a fashion to allow S29 to dominate the culture,
thus eliciting a chemical response from the addition of each
fungus. Bioassay-guided fractionation lead to no lead com-
pounds as potential antifungal agents yet post-fermentation
streaks of inoculum showed no fungal growth. High resolution
LC-MS/MS followed by GNPS molecular networking was used to
analyse the data sets. The results indicated that not only is
Streptomyces sp. S29 extraordinary at producing hydroxamate
siderophores, totalling 24 new analogues and 8 previously
identified ones confirmed through MS/MS structure elucida-
tion, but uses siderophore production as a means to ‘starve’
the fungi of iron. When grown in coculture with the fungi,
22 additional new analogues and 17 additional previously
described were identified, clearly showing a chemical response
to the fungi in culture environment. Using MS2LDA to further
explore desferrioxamine chemical space, we observed that it is
potentially 2.5 times larger than previously anticipated. These
results point to the potential of Streptomyces sp. S29 as a
biocontrol agent to prevent fungal infection and the potential
for new desferrioxamine chemistry.
Results and discussion
Streptomyces sp. S29 cocultivation and LC-MS of
desferrioxamine-rich fractions
Preliminary fungal bioassay screening of the lupine rhizo-
sphere Streptomyces culture collection showed a novel strain,
Streptomyces sp. S29, inhibited the growth of Botrytis cinerea
when grown in coculture on solid medium (Fig. 1). In an
attempt to induce production of antifungal metabolites, the
bacteria and fungi were cocultivated in liquid culture in a
fashion to allow for Streptomyces sp. to be the dominant
microbe. Bioassay guided fractionation of the sec-butanol frac-
tion lead to no antifungal leads even though inhibition was
observed against B. cinerea only (Fig. S6, ESI†). Upon LC-MS
and 1H NMR analysis of the extracts, a profusion of DFOs was
observed in all sec-butanol fractions, leading to the hypothesis
that this Streptomyces sp. uses a different mechanism than
producing antimycotics to combat the fungal cocultivate, as seen
Fig. 1 Preliminary antifungal screening on Streptomyces isolate S29
(right) grown with Botrytis cinerea (left). Image courtesy of Diego Lagos-
Susaeta.
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previously in human bacterial infections.33 DFOs historically have
never exhibited antimicrobial activity and therefore we confidently
presume they are not responsible for the inhibition seen in Fig. S6
(ESI†).34 Time-dependent growth inhibition of Penicillium was
observed when exposed to varying concentrations of copropor-
phyrin, a siderophore produced by Glutamicibacter arilaitensis,35
but this activity has never been shown for desferrioxamines.
Streptomyces sp. S29 was also grown in monoculture on iron
deficient medium to induce production of DFOs in an attempt
to compare siderophore production to the coculture experiments.
Aspergillus niger and Botrytis cinerea were chosen as the fungal
phytopathogens due to their established pathology of wine produ-
cing grapes36,37 and the importance of wine as Chile’s main
agricultural export. Additionally, these fungi would be encoun-
tered in Streptomyces sp. S29’s ecological niche, making this an
important evaluation of microbes it would encounter in the soil
environment.
Extracts and fractions were evaluated for the presence of
two DFOs (B and D1) during the fractionation steps, in order to
trace the fractions that contained the highest abundance of
siderophores. Presence of DFOs was further evaluated at the
final stages of separation based on the molecular families generated
from molecular networking, utilizing the known DFOs in the GNPS
library as anchor points, which further aided structure elucidation.
Based on the LC-MS results, the butanol partitions contained the
largest abundance of DFOs, and therefore this data was used to
generate a molecular network using GNPS.
Molecular networking and MS/MS based structure elucidation
The molecular network generated contained 1169 molecular
features after removal of features originating from media and
instrument blanks. Each subnetwork was approached using
GNPS library hits as ‘anchors’ (hexagons in each subnetwork)
and then collecting the masses of linked nodes and predicting
molecular formula from the raw data. Using these ‘anchors’ not
only allows one to relate the nodes directly connected to the
anchor but also gives broader sense of the molecular nature of a
cluster. The hydroxamate siderophores were primarily distri-
buted amongst three principal molecular families (Fig. 2–4).
Subnetwork 1 (Fig. 2) contained a number of new acyl DFO
D-like analogues that are first described in this study as well as
new analogues of acyl DFO B-like derivatives. Subnetwork 2
(Fig. 3) is mostly composed of unknown derivatives although a
suite of new macrocyclic DFOs and tenacibactin derivatives,
first described by Jang et al.,38 were observed. The last principal
subnetwork contained various Fe(III) and Al(III) complexed
ferrioxamines (FO) (Fig. 6). Within this network a new analogue
was identified, uC12 acyl FO-B, while its non-chelated form was
not observed in the data (Fig. S32, ESI†).
Aryl desferrioxamines related to the previously described acyl
ferrioxamine 1 (also known as legonoxamine A) and 2 were also
found distributed amongst varying molecular families across the
molecular network and do not seem to link into their own cluster
such as that seen for the DFO-Ds and DFO-Bs. For the remaining
small molecular families that contain DFOs, we observed a group of
Fig. 2 Desferrioxamine subnetwork 1. Distributed amongst the molecular family are DFO-Bs (blue), DFO-Ds (red), and aryl DFOs (purple). Grey nodes
represent potential DFOs that were not able to be annotated using MS/MS data only.
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sodiated adducts, large acyl DFO-Bs, as well as the macrocyclic
desferrioxamine E (Fig. S1, ESI†). The remaining nodes that link
within the desferrioxamine molecular families were unable to be
identified using the annotation workflow described in Fig. 4.
Fig. 3 Desferrioxamine subnetwork 2. Within the molecular family are macrocyclised DFOs (green) as well as a number of new tenacibactin derivatives
(orange). Grey nodes represent potential DFOs that were not able to be annotated using MS/MS data only.
Fig. 4 Molecular network and MS/MS based structure determination. (A) molecular networks generated using GNPS were dereplicated and potentially
unknown ions were found in the Raw data. (B) Predicted molecular formula were generated and the most likely candidate formula was chosen. MS/MS
spectra were analysed for the initial loss of 118 or 160 to determine the N-terminal moiety of N-hydroxycadaverine or N-acetylhydroxycadaverine,
respectively. (C) Based on known structure of desferrioxamines, substructures were proposed for each new metabolite and lastly, (D) putative structures
were supported by MS/MS data, although further spectroscopic characterisation would be required for confirmation.
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MS/MS based structure elucidation was carried out in a
similar fashion to studies conducted previously (Fig. 4).25–28
Early observations of desferrioxamine B and D1 fragmentation
showed an initial loss of the N-terminus, corresponding to the
loss of either 118.1 or 160.1. Using this as a foundation,
structures were either started with a N-hydroxycadaverine or a
N-hydroxy-N-acetylcadaverine, respectively. The remainder of
structure elucidation was completed stepwise: (1) predicting
the molecular formula from the accurate mass and collection of
MS/MS data, (2) filling out the structures with appropriate
desferrioxamine precursors (i.e. N-hydroxycadaverine, putres-
cine, succinate, acetate, etc.), and (3) taking the remainder of
the molecular formula and placing an appropriate acid at the
C-terminus that either has precedent from previous studies or
could be a potential binding partner with an acyltransferase
like coenzyme A.
Overall, 41 new DFO analogues were identified in the
molecular network and through manual data processing (Table 1).
These range from short acyl chain DFO-Bs, acyl desferrioxamine
D-like (DFO-D) analogues which have not previously been described,
tenacibactins, aryl DFOs, and long chain dicarboxylate DFOs
(Table 1). Additionally, 5 macrocyclic (with uncertain structures)
and 25 known hydroxamate siderophores were detected, including
known acyl, aryl DFOs and bisucaberins, giving further credence
to the new structure assignments. Their identification, observed
presence in monoculture and/or coculture, and identification con-
fidence based on Schymanski’s rules39 are present in Table 1.
Schymanski’s rule distinguish various levels of confidence for mass
spectral-based assignments, where the highest score is 1 (verifiable
by MS, MS2, RT, and an internal standard) and the lowest score is 5
(exact mass only). The majority of the identified compounds rank at
level 2 or level 3 on the Schymanski scale.
Acyl DFO production by Streptomyces sp. S29
Streptomyces sp. S29 was able to produce twelve new acyl
DFO-Bs similar to those previously described.26,27 Of these 12,
five were short acyl chain derivatives (C3, C4, C4 hydroxylated,
C5, and C6), five were monounsaturated derivatives (uC6, uC7,
uC10, uC11, and uC12), and two were derivatives containing
glutaric acid at the C-terminus, similar to those seen by
Rütschlin et al.40 Pertaining to the unsaturated derivatives,
placement of the alkene at the position a to the carbonyl is
based off previous studies also reporting DFOs containing
unsaturated acyl chains.27,41 Additionally, the position of the
hydroxyl in the C4 derivative was based on previous work
showing multiple amphiphilic peptide-based siderophores
contain hydroxylation at the b-position.27,42
We propose henceforth that the previously known ‘acyl
DFOs’ should be renamed ‘acyl DFO-B’ due to the observation in
this study of analogues that contain a N-acetyl-N-hydroxycadaverine
terminus, similar to desferrioxamine D. The new acyl DFO-D
analogues discovered here also range from short, medium and
long acyl chained derivatives (Table 1). It is likely the acyl DFOs are
branched analogues as previous studies noted that it was unlikely
the chains were fully linear since Streptomyces spp. utilise branched
starter units in fatty acid synthesis.26,27 This is also the case for the
suite of tenacibactin analogues observed in the data. These
branched acyl chain siderophores were originally observed in
Tenacibaculum sp. A4K-17,38 and are essentially truncated versions
of acyl DFO-Bs that lack the N-terminal N-hydroxycadaverine.
Streptomyces coelicolor has shown broad substrate specificity
in regard to medium and long acyl chain incorporation into
desferrioxamine structures,19 but not short acyl chained
groups, where Streptomyces sp. S29 can facilitate production
of short, medium, and long acyl chained DFO-B analogues.
Traxler et al. showed the ability of other Actinobactera to react
to the presence of S. coelicolor through the production of acyl
DFO-B analogues.26 Interestingly, we see this same phenom-
enon for the coculture of Streptomyces sp. S29 and the fungi.
Medium and long chained acyl DFO-Bs (including unsaturated
derivatives) were almost exclusively produced in coculture
whereas short, medium and long chained acyl DFO-Ds were
produced under both mono- and coculture conditions. The
tenacibactin analogues were distributed amongst both cultures
(Table 1). It was hypothesized these long-chained derivatives
might be a way for the uptake of these analogues to bypass the
DesE uptake mechanism, instead they ‘hand-off’ the Fe(III) via
membrane bound ferrioxamines.19,43
Aryl DFO production by Streptomyces sp. S29
The production of seven new aryl DFOs related to legonox-
amine A and B, which were also observed in this study (Table 1),
shows the biosynthetic flexibility of Streptomyces sp. S29. These
structures range from being smaller, potential oligomers like
legonoxamine C (m/z 351.1912, Fig. S12, ESI†) to the larger
legonoxamine H (m/z 665.3893, Fig. S17, ESI†). A few interesting
legonoxamine derivatives include legonoxamine F (Fig. S15, ESI†),
putrescine-containing legonoxamine G (Fig. S15, ESI†) and
legonoxamine A glycoside (Fig. S18, ESI†).
Legonoxamine F contains one 1,6-diaminohexane instead
of cxthe typical 1,5-diaminopentane. This is a well-established
phenomenon in siderophore biosynthesis31,44 linking it to the
promiscuity of the S29 des biosynthetic gene cluster. Legonox-
amine G contains a N-hydroxyputrescine moiety due to the
initial loss of 104 Da instead of the typical 118 Da associated to
N-hydroxycadaverine. Putrebactin is the archetypal putrescine
containing siderophore,45 and as its biosynthetic gene cluster
has been shown to lack genes coding for production of putres-
cine, it is assumed that instead, this precursor is sequestered
from metabolite pools.46 Interestingly, researchers have also
found that under putrescine-depleted conditions, Shewanella
putrefaciens shifts to producing desferrioxamine B when cadaverine
precursors are available.47 In desferrioxamine biosynthesis,
incorporation of the putrescine precursor in desferrioxamine
A1 has been shown before in multiple species30,44,48 and now in
this study with the discovery of legonoxamine G.
Legonoxamine A glycoside was observed using the predicted
molecular formula (C37H62N6O13) and the loss of a sugar (162 Da).
An additional putative diglycosylated DFO (m/z 899.4827), with a
predicted molecular formula of C38H70N6O18, was observed in
the mass spectrum but upon selected ion monitoring (SIM),
produced insufficient fragment ions for structural characterisation.
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Table 1 Summary of siderophores identified using molecular networking and manual observations of the data
Name
Measured
mass [M + H]+
Theoretical







Bisu-03 429.2344 429.2342 0.46 C19H33N4O7 2 Senges et al.
Bisu-01 443.2495 443.2500 1.13 C20H35N4O7 2 Senges et al.
Uncertain structure 457.2660 457.2657 0.65 C21H37N4O7 3 * This study
Uncertain structure 499.3110 499.3126 3.20 C24H43N4O7 3 * This study
Uncertain structure 513.3310 513.3283 5.25 C25H45N4O7 3 * This study
Uncertain structure 527.3450 527.3439 2.08 C26H47N4O7 3 * This study
Uncertain structure 583.4050 583.4065 2.57 C30H55N4O7 3 This study
Desferrioxamine E 601.3557 601.3556 0.17 C27H49N6O9 2
Aryl
desferrioxamines
Legonoxamine B 337.1754 337.1758 1.19 C17H25N2O5 2 Maglangit et al.
Legonoxamine C 351.1912 351.1914 0.57 C18H37N4O5 3 This study
Legonoxamine D 437.2755 437.2758 0.69 C22H37N4O5 3 This study
Legonoxamine E 537.2924 537.2919 0.93 C26H41N4O8 3 * This study
Legonoxamine F 551.3088 551.3075 2.36 C27H43N4O8 3 This study
Legonoxamine G 623.3764 623.3763 0.16 C30H51N6O8 3 * This study
Acyl-ferrioxamine
1/legonoxamine A
637.3917 637.3919 0.31 C31H53N6O8 2 * D’Onofrio et al.;
Maglangit et al.
Legonoxamine H 665.3893 665.3869 3.61 C32H53N6O9 3 This study
Acyl-ferrioxamine 2 679.4025 679.4025 0.00 C33H55N6O9 2 * D’Onofrio et al.
Legonoxamine A
glycoside
799.4456 799.4448 1.00 C37H63N6O13 3 * This study
DFO-Bs Un-pre[5 + 5*] 431.2500 431.2520 4.63 C19H35N4O7 3 This study
Pre[5 + 5*] 433.2662 433.2657 1.15 C19H37N4O7 2 Rütschlin et al.
Pre[5 + 5*] aldehyde 447.2450 447.2449 0.22 C19H35N4O8 3 This study
Pre[ha + 5 + 5*] 517.3221 517.3232 2.12 C24H45N4O8 2 Rütschlin et al.
Abloxime/IC202C 517.3347 517.3344 0.58 C23H45N6O7 2 * Iijima et al.
Proferrioxamine G1t 519.3495 519.3501 1.16 C23H47N6O7 2 Feistner et al.
DesuA1 545.3658 545.3657 0.18 C25H49N6O7 2 * Senges et al.
DesA1 547.3449 547.3450 0.18 C24H47N6O8 2 * Senges et al.
Des A2/IC202B 557.2880 557.2881 0.18 C23H43N6O8Al 2 Iijima et al.
Desferrioxamine B 561.3602 561.3606 0.71 C25H49N6O8 2 *
Desferrioxamine
N/desf-05
575.3762 575.3763 0.17 C26H51N6O8 2 * Ejje et al.;
Senges et al.
C3 acyl DFO-B 589.3915 589.3919 0.68 C27H53N6O8 2 * This study
C4 acyl DFO-B 603.4073 603.4076 0.49 C28H55N6O8 2 * This study
C5 acyl DFO-B 617.4233 617.4232 0.16 C29H57N6O8 2 * This study
C4 acyl hydroxylated
DFO-B
619.4024 619.4025 0.16 C29H55N6O9 3 * This study
uC6 acyl DFO-B 629.4238 629.4232 0.95 C30H57N6O8 3 This study
C6 acyl DFO-B 631.4388 631.4389 0.16 C30H59N6O8 2 * This study
uC7 acyl DFO-B 643.4389 643.4389 0.00 C31H59N6O8 3 This study
C7 acyl-DFO 645.4550 645.4545 0.77 C31H61N6O8 2 Traxler et al.;
Sidebottom et al.
C8 acyl-DFO 659.4697 659.4702 0.76 C32H63N6O8 2 Traxler et al.;
Sidebottom et al.
uC10 acyl DFO-B 685.4856 685.4858 0.29 C34H65N6O8 3 This study
uC11 acyl DFO-B 699.5007 699.5025 2.57 C35H69N6O8 3 This study
C11 acyl-DFO 701.5174 701.5171 0.43 C35H69N6O8 2 Traxler et al.;
Sidebottom et al.
C12 acyl-DFO 715.5322 715.5328 0.84 C36H71N6O8 2 Traxler et al.;
Sidebottom et al.
C13 acyl-DFO 729.5496 729.5484 1.64 C37H73N6O8 2 Traxler et al.;
Sidebottom et al.
uC12 acyl FO-B [M + Al]+ 737.4776 737.4752 3.25 C36H66N6O8Al 3 This study
Dodecanedioic DFO-B 745.5086 745.5070 2.15 C36H69N6O10 3 This study
Amphiphilic
desferrioxamine 12
745.5438 745.5434 0.54 C37H73N6O9 2 Sidebottom et al.
Tridecanedioic DFO-B 759.5221 759.5226 0.66 C37H71N6O10 3 This study
Amphiphilic
desferrioxamine 15
759.5597 759.5590 0.92 C38H75N6O9 2 Sidebottom et al.
DFO-Ds Desferrioxamine H 461.2602 461.2606 0.87 C20H37N4O8 2 Adapa et al.
Glutaric
desferrioxamine H
475.2760 475.2762 0.42 C21H39N4O8 2 This study
C2 acyl glutaric
desferrioxamine H
489.2900 489.2919 3.88 C22H41N4O8 2 This study
Desferrioxamine D4 559.3453 559.3450 0.50 C25H47N6O8 2 This study
Deoxydesferrioxamine D3 587.3757 587.3763 1.02 C27H51N6O8 3 * This study
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The production of glycosylated DFOs has only been reported once
before: nocardamin glucuronide, isolated from Streptomyces sp.
80H647.49 There are only a few reports of microbial enzymes that
produce glucuronides,50 yet, the addition of glucose or other
hexoses are more commonplace in bacterial natural products.
We propose legonoxamine A glycoside undergoes a similar
glycosylation mechanism to nocardamin glucuronide, occur-
ring on a N-hydroxyl.
Macrocyclised desferrioxamines
We observe desferrioxamine E in the molecular network
(Fig. S1, ESI†) as well as several other macrocyclic DFOs.
In Fig. 3, these are anchored by bisucaberin 01 (m/z 443), first
described by Senges et al.28 Based on the molecular formulas,
fragmentation patterns and the previously established structure,
we observe multiple additional macrocyclic derivatives connected
via bisucaberin 01 but their structures were not definable based
on MS/MS data alone (Table 1). The putative macrocyclised
derivatives extend by successive CH2’s, differing from the study
by Senges et al. which reduce in size, but the location of this
extension requires confirmation via NMR. Similar to acyl DFOs,
macrocyclic derivatives have also shown to have flexible bio-
synthesis in feeding studies, including the incorporation of
1,8-diaminooctane moieties.51 There was no observation of
putrebactin, or avaroferrin in the culture despite the similar
biosynthesis with bisucaberins and desferrioxamines.
Dicarboxylic acid desferrioxamine analogues
Two new desferrioxamines, observed only in coculture extracts,
with dicarboxylic acid C-termini were also elucidated. Dodeca-
nedioic DFO-B (Fig. S33, ESI†) has an m/z of 745.5086,
corresponding to the molecular formula of C36H68N6O10. Tri-
decanedioic DFO-B (Fig. S34, ESI†) has an m/z of 759.5221,
corresponding to the molecular formula of C37H70N6O10. This
is the first reported instance of large dicarboxylic acids being
incorporated into DFO structures yet there are examples of
larger dicarboxylic acids being bound to CoA, like pimelic acid,
therefore we cannot rule the possibility out.
Microbial cytochrome p450s are responsible for adding
complexity to fatty acids to be used as building blocks for more
complex metabolites or as signalling molecules.52 Previous
studies have shown the bacterial production of dicarboxylic
acids might occur via cytochrome p450 monoxygenase.53
In order to determine the presence of enzymes that facilitate
o-oxidation in S29, protein sequences that belong to the long-
chain fatty acid o-monooxygenase enzyme class (EC 1.14.14.80)
and from fatty acid o-oxidation gene ontology (GO:0010430)
were obtained from the Uniprot database. BLAST results of
these sequences against the S29 draft genome reveals just one
hit (Supplementary data, ESI†), comprising 3 orthologs with
mid-term amino acid identity (40–50%), a methyl-branched
lipid o-hydroxylase (cyp124) from Mycobacterium spp. (B43%
identity) (Uniprot: P9WPP2, P0A517 & P9WPP3). Pfam sequence
search confirms cytochrome P450 domain for this protein and
further experimentation could confirm its o-monooxygenase
activity. Searching Uniprot under these search criteria returns
only a handful of bacterial sequences with a couple belonging
to Actinobactera, therefore, the possibilities to track this activity in
the S29 genome are very narrow resulting in an inconclusive result
regarding the presence of an o-monooxygenase in S29.
Ferrioxamines and DFO presence in pure and coculture
experiments
A number of metal complexed ferrioxamines were observed in
subnetwork 2 (Fig. 6). Fe(III) and Al(III) are the only metals
complexed with the variety of desferrioxamines present, similar
to studies before.26,27 Although the binding affinity for Fe(III) is
greater than Al(III),54 it appears that this difference in affinity
is not enough to prevent Al(III) chelation. The importance of
iron has already been addressed in regard to bacteria and cell
Table 1 (continued )
Name
Measured
mass [M + H]+
Theoretical





Desferrioxamine D3 589.3915 589.3919 0.68 C27H53N6O8 2 * This study
Desferrioxamine D1 603.3714 603.3712 0.33 C27H51N6O9 2 *
C2 acyl DFO-D 617.3864 617.3869 0.81 C28H53N6O9 2 This study
C4 acyl DFO-D 645.4185 645.4182 0.46 C30H57N6O9 2 * This study
C5 acyl DFO-D 659.4331 659.4338 1.06 C31H59N6O9 2 This study
C6 acyl DFO-D 673.4498 673.4495 0.45 C32H61N6O9 2 * This study
C7 acyl DFO-D 687.4655 687.4651 0.58 C33H63N6O9 2 * This study
C11 acyl DFO-D 743.5280 743.5277 0.40 C37H71N6O9 2 * This study
C12 acyl DFO-D 757.5436 757.5434 0.26 C38H73N6O9 2 * This study
C13 acyl DFO-D 771.5607 771.5590 2.20 C39H75N6O9 2 * This study
C14 acyl DFO-D 785.5749 785.5747 0.25 C40H77N6O9 2 * This study
Tenacibactins Tenacibactin C 503.3070 503.3075 0.99 C23H43N4O8 3 Jang et al.
Tenacibactin E 531.3380 531.3388 1.15 C25H47N4O8 3 * This study
Tenacibactin F 545.3545 545.3545 0.00 C26H49N4O8 3 * This study
Tenacibactin G 587.3990 587.4014 4.08 C29H55N4O8 3 This study
Tenacibactin H 601.4168 601.4171 0.49 C30H57N4O8 3 * This study
Tenacibactin I 615.4326 615.4327 0.16 C31H59N4O8 3 This study
Tenacibactin J 629.4484 629.4484 0.00 C32H61N4O8 3 This study
Nomenclature that are italicized were identified in this study.
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maintenance but Al(III) is toxic and has no direct role in
metabolism and seems to be an consequence of the chemical
ecology of these metabolites.
The molecular network was also used to evaluate the pro-
duction of the DFOs between the two cocultivations with
A. niger and B. cinerea and the Streptomyces sp. S29 monoculture
(Fig. S3, ESI†). The results showed that 32 of the 71 ions were
present in the monoculture, whereas all of the remaining were
found in coculture extracts only (Table 1). There was no
qualitative significant difference in the siderophores produced
under cocultivation with A. niger compared to those produced
in cocultivation with B. cinerea, indicating the potential broad
response to a fungal microbe in the environment. These results
might point to DFO and siderophore production in a broader
context as a common chemical response to other microbes,
whether it be bacterial or fungal, in close environmental
proximity to the primary organism.
MS2LDA analysis
In order to further evaluate the overall chemical space that
DFOs inhabit in the molecular network, MS2LDA was performed.
MS2LDA is a technique which identifies molecular ‘fingerprints’
in fragmentation patterns and assigns these into motifs
(13 Mass2Motifs were manually curated). By merging the two
networks (GNPS molecular network and MS2LDA) after motifs
were annotated, it is clear that further DFO chemical space is
there to be discovered. Fig. S4 (ESI†) represents the overall
results of this merged network where we have highlighted the
previously identified features (107) and edges (970) from the
original molecular networking job and all of the nodes (351)
and edges (1991) that contain DFO motifs identified through
MS2LDA. This near tripling of features by inclusion of the
MS2LDA workflow doesn’t necessarily correlate to an increase
in metabolites, but upon validation of the data, there seems to
be very minimal features corresponding to isotopes or adducts.
In order to evaluate the accuracy of this analysis, a charac-
terized DFO in this study (legonoxamine E, Fig. 5) and an
unknown DFO observed using MS2LDA (m/z 650.37, [M +
2H]2+) were more closely analysed (Fig. S5, ESI†). The unknown
desferrioxamine is a singleton (Fig. S5B, ESI†) in both
the original network and the merged network, yet, MS2LDA
identifies it contains DFO motifs and upon closer inspection
and prediction of its molecular formula (C59H103N12O20). The
potential of this putative DFO being a dimer was ruled out
Fig. 5 Representation of desferrioxamine structural diversity of Streptomyces sp. S29. (A) and (B) new legonoxamine derivatives (purple), tenacibactins
(orange), DFO-Ds (red), and a variety of DFO-Bs (blue) were all found. Full MS/MS data and annotations can be found in ESI† for all 41 new analogues
discovered.
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based on fragmentation analysis lacking the monomer.
Elucidation of its full structure was not able to be completed
with MS/MS data alone, therefore, further studies are underway
to characterise its structure. Nonetheless, this example displays
the utility of MS2LDA to evaluate the chemical potential of a
bacterium and its potential use in these types of studies in the
future.
Streptomyces sp. S29 siderophore biosynthetic gene clusters
DFOs are biosynthesized by nonribosomal peptide synthetase
independent siderophore (NIS) pathways and the presence of at
least one gene encoding a homolog to IucA/IucC has become
recognized as a marker of NIS biosynthetic gene clusters.55
DFO biosynthesis is encoded by the highly conserved des
biosynthetic gene cluster (desEFABCD genes) found in many
Streptomyces species.21 Using FeGenie,56 the identification of
iron-related genes revealed 27 siderophore biosynthesis and 11
transport related genes in the Streptomyces sp. S29 genome.
These siderophore biosynthesis related genes are grouped in
five biosynthetic gene clusters and antiSMASH57 predictions
reveal that three of the five contain at least one gene homolog
to IucA/IucC and the other two correspond to NRPS dependent
pathways.
Region 7 (Fig. S53, ESI†) contains a siderophore BGC in
Streptomyces sp. S29 with high homology to desA-D genes and to
the ferric-siderophore uptake and utilization genes (desE-F).
This des cluster follows the same structure as many Streptomyces
spp., including the position of iron boxes upstream putative desE
(s29_002291) and desA (s29_002293) genes (Fig. S31, ESI†). DesC
of the des BGC from Streptomyces sp. S29 (s29_2295) exhibits high
identity to DesC from S. coelicolor (72%) and to LgoC from
Streptomyces sp. MA37 (69%). In S. coelicolor A3(2), transcription
of des BGC is repressed by the divalent metal-dependent regula-
tory (DmdR) protein DmdR1 and derepressed by iron limitation.58
BLASTN/P analysis revealed a putative DmdR repressor in
Streptomyces sp. S29 (s29_002782) with 89% nucleotide and 93%
amino acid identity to DmdR1 (AJ271797.1/CAC28070.1). BLASTN
analyses identified eight putative DmdR-binding sites (iron boxes)
in Streptomyces sp. S29 by query of putative iron boxes found
upstream in different ORFs in S. coelicolor A3(2) genome.19
Acyltransferases involved in hydroxamate biosynthesis
normally exhibit narrow substrate tolerance (e.g. IucB, which
shows a high degree of specificity towards acetyl-CoA).19 The
array of DFOs produced by S. coelicolor (B, E, G1 and amphi-
philic) and aryl DFOs (legonoxamine A-B) produced by Strepto-
myces sp. MA37, has been attributed to substrate tolerant
acyltransferases DesC and LgoC, respectively.19,59 Senges et al.
acknowledged in their evaluation of the Streptomyces chartreusis
secretome that in iron depleted minimal medium they also
observed additional desferrioxamines produced and that the
overall biosynthetic potential may be much broader than what
has been predicted.28 Cloning and more detailed analysis of the
Streptomyces sp. S29 des gene cluster is ongoing to link the
chemical potential shown in this study.
In conclusion, the chemistry observed in the Streptomyces
sp. S29 secretome shows it potential as an agent to prevent
Fig. 6 Metal-complexed molecular families. The GNPS library was able to identify multiple metal ion complexes (hexagonal nodes). All other features
observed in the molecular network were assignable as Fe(III) or Al(III) bound ferrioxamines. Table S1, ESI† contains accurate mass information on all
complexed ions found in this figure.
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fungal infection, evidenced by its locking away of Fe(III) via
overproduction of desferrioxamines. New analogues were
observed in both monoculture and cocultivation studies with
fungal phytopathogens, A. niger and B. cinerea. Streptomyces sp.
S29 seems to produce an arsenal of desferrioxamine analogues
using any available precursor materials available whether that
be putrescine, cadaverine, aryl, acyl, or long chained dicarbox-
ylates. The role of bacterial communities in plant and crop
protection is becoming more important due to the growing
world population, with a strong emphasis on improving stra-
tegies at preventing phytopathogenic infection. Overall, the
production of 46 new and 25 previously reported siderophores
indicates this Streptomyces sp. should be studied further for its
plant protective properties as a biocontrol agent.
Experimental section
Strain collection
Streptomyces sp. S29 was isolated from a soil sample collected
from Lupine plant (Lupinus oreophilus) roots originating from a
polyextreme enviroment at Quebrada Nacimiento, Socaire, San
Pedro de Atacama, Atacama Desert (2313700600S;6715005600W –
3.646 m.a.s.l.). One aliquot was heated at 100 1C for 5 min and
directly sprinkled onto Gause #1 and Starch-Casein plates, both
complemented with nystatin, cycloheximide and nalidixic acid.
Another aliquot was resuspended in 1/4 Ringer solution, heated
at 60 1C for 10 min and dilutions of 101/2 and 101 were spread
onto agar plates. Plates were incubated at 30 1C for B1 week
and colonies were subcultured on ISP2 plates. Based on mor-
phological characteristics of the colony and antifungal activity
experiments against B. cinerea and A. niger, 16S rRNA sequence
of S29 isolate was used to identify and confirm its taxonomy
using EzBioCloud database (3) (data not shown).
Phytopathogens
Aspergillus niger and Botrytis cinerea, biochemically charac-
terized field samples, were provided by Laboratorio de micro-
biologı́a, Facultad de Ciencias naturales, matemática y medio
ambiente, Universidad Tecnológica Metropolitana (UTEM),
Santiago, Chile. Molecular identification of these strains was
carried out by sequencing of internal transcribed spacer (ITS)
region amplified by PCR using universal primers ITS1 and ITS4
(Supplementary data, ESI†).
Biological screening
Preliminary antifungal screening of the lupine rhizosphere
Streptomyces collection was carried out starting from spore
stocks, where Streptomyces isolates were grown on ISP2 at
30 1C for 1 week. On PDA plates, two inverted agar plugs
(different isolates) from these ISP2 plates, set at 2 cm from
the centre, were grown at 30 1C O.N. After this, the centre of the
PDA plates was inoculated using 10 mL of a 5  104 spores per
mL spore stock of a phytopathogen (Botrytis/Fusarium) and
grown at 25 1C. Inhibition observations were carried out at 4,
11 and 17 days from pathogen inoculation.
Disc diffusion assays were adapted for the microbes tested
using the Clinical and Laboratory Standards Institute M44
Method for Antifungal Disk Diffusion Susceptibility Testing of
Yeasts.60 Extract concentrations were standardised to 200 mg mL1
for all bioassays conducted.
In order to conduct post-fermentation streaks, 50 mL of
fermentation was aseptically transferred onto a ISP2 agar plate.
24 and 48 hour incubation (28 1C) intervals were checked
for fungal growth. Due to the faster growth rate of the fungi,
we would expect any presence of fungal spores to lead to
the observation of mycelial growth, yet no fungal growth was
observed.
Cocultivation and extraction
A set of experiments were carried out on these three organisms
in order to determine the effect of the fungal culture being
added to the Streptomyces sp. (a) Streptomyces sp. S29 alone: a
single colony was aseptically transferred to 100 mL of iron
deficient medium (ISP2), shaken at room temperature at 150 RPM
for 7 days, in order to induce production of siderophores.
(b) Streptomyces sp. S29 + Aspergillus niger: 100 mL of bacterial
culture was grown for 5 days, at room temperature and shaken at
150 RPM. On the second day of bacterial growth, an independent
axenic culture of A. niger (spores) was grown for 3 days (10 mL of
PDA liquid medium, room temperature and 150 RPM shaking).
On the fifth day of bacterial growth, the fungal liquid culture was
transferred axenically to the bacterial culture and allowed to grow
an addition 2 days. (c) Streptomyces sp. S29 + Botrytis cinerea: the
same procedure as described in experiment b was followed.
Additionally, each experiment contained 3 g/50 mL of sterilised
glass beads to prevent aggregation. Each coculture was then
scaled up to 3 L total volume in an attempt to produce sufficient
secondary metabolites for structure elucidation.
Each liquid fermentation included Diaion HP-20 resin
(3 g/50 mL) that was sterilised with culture medium. After
7 days, the resin was vacuum filtered, subsequently washed
five times with Milli-Q water and finally macerated exhaustively
in methanol (3). The methanolic extract was then dried on a
rotary evaporator and subsequently underwent Kupchan
partitioning.61 Finally, the sec-butanol fraction underwent C18
solid-phase extraction (Phenomenex), with each separation
yielding 5 fractions of increasing methanol and these samples
were subsequently prepared for LC-MS studies.
The 100% methanol fractions from the Botrytis and
Aspergillus co-culture were subjected to further separation via
reversed phase-HPLC with a Waters Sunfire C18 semi-preparative
column (5 mM, 100 Å, 250  10 mm) wand a solvent system of
A-95/5 MeOH/H2O and B-MeOH. The Agilent 1200 HPLC utilized a
solvent gradient of 0% B to 100% B at 2.0 mL min1 over 50 min.
Liquid chromatography – mass spectrometry
All runs were analysed using an Agilent 1290 UHPLC coupled
to Bruker MAXIS II Q-ToF mass spectrometer. LC utilizes a
Phenomenex Kinetex XB-C18 (2.6 mM, 100  2.1 mm) column
with a mobile phase of 5% MeCN + 0.1% formic acid to 100%
MeCN + 0.1% formic acid in 11 min. Bruker MAXIS II has a
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mass range of m/z 100–2000, capillary voltage 4.5 kV, nebulizer
gas 5.0 bar, dry gas 12.0 l min1, and dry temperature of 220 1C.
MS/MS experiments were conducted under Auto MS/MS scan
mode with a step collision energy from 80–200%. Samples were
prepared at a concentration of 0.3 mg mL1. Raw data files were
analysed using Bruker Daltonics 3.6.
GNPS molecular networking and MS2LDA
A molecular network was created using the online workflow
(https://ccms-ucsd.github.io/GNPSDocumentation/) on the GNPS
website (http://gnps.ucsd.edu). The data was filtered by removing
all MS/MS fragment ions within 17 Da of the precursor m/z.
MS/MS spectra were window filtered by choosing only the top 6
fragment ions in the 50 Da window throughout the spectrum.
The precursor ion mass tolerance was set to 0.02 Da and a MS/MS
fragment ion tolerance of 0.02 Da. A network was then created
where edges were filtered to have a cosine score above 0.7 and
more than 5 matched peaks. Further, edges between two nodes
were kept in the network if and only if each of the nodes appeared
in each other’s respective top 10 most similar nodes. Finally,
the maximum size of a molecular family was set to 100, and the
lowest scoring edges were removed from molecular families until
the molecular family size was below this threshold. The spectra in
the network were then searched against GNPS’ spectral libraries. The
library spectra were filtered in the same manner as the input data.
All matches kept between network spectra and library spectra
were required to have a score above 0.7 and at least 6 matched
peaks. All features originating from the medium/instrument
blanks were excluded from the final molecular network.
For documentation on running MS2LDA, the user is referred
to the original publication and guidelines, which are also present
at ms2lda.org.62 All spectral images in the ESI† were created using
Metabolomics Spectrum Resolver (https://metabolomics-usi.
ucsd.edu/).63
All siderophores dereplicated and elucidated in this study
can be found in Table 1. The structure elucidation of each new
derivative and its corresponding MS/MS spectra were generated
using Metabolomics Spectrum Resolver are displayed in the
ESI† (Table S2 and Fig. S7–S52). All MS/MS spectra were also
annotated and deposited in the GNPS library, as well as the
original datasets (Table S2, ESI†).
All data files and workflows can be found at the links below:
GNPS molecular networking job: https://gnps.ucsd.edu/Proteo
SAFe/status.jsp?task=3c73305ef7ed48e19cb18e50b8b6b2bd.
MS2LDA annotation experiment: http://ms2lda.org/basicviz/sum-
mary/1319/. MASSIVE: doi:10.25345/C5772V.
Streptomyces sp. S29 genome sequencing and assembly
Streptomyces sp. S29 total DNA was extracted from liquid
culture using DNeasy UltraClean Microbial Kit (Qiagen). Whole
genome sequencing (WGS) of the strain was performed by
an Illumina MiSeq (2  300 PE). Nanopore sequencing was
performed using a Rapid Sequencing Kit (SQK-RAD004)
and MinIon Flow Cell (R9.4.1). The sequence was assembled
using Canu, polished using Racon, Illumina dataset was
mapped onto the contigs using BWA mem and then corrected
using Pilon. The genome was annotated using NCBI pgap
software (6).
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